Natixis Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$357M Buy
2,970,290
+442,713
+18% +$51.1M 0.5% 26
2025
Q4
$266M Buy
2,527,577
+217,330
+9% +$20.4M 0.38% 46
2025
Q3
$194M Buy
2,310,247
+371,039
+19% +$30.6M 0.28% 71
2025
Q2
$154M Buy
1,939,208
+475,556
+32% +$37.8M 0.24% 86
2025
Q1
$131M Sell
1,463,652
-175,562
-11% -$16.4M 0.24% 95
2024
Q4
$163M Buy
1,639,214
+407,368
+33% +$42M 0.3% 64
2024
Q3
$140M Sell
1,231,846
-124,336
-9% -$14.8M 0.27% 77
2024
Q2
$168M Buy
1,356,182
+80,663
+6% +$10.4M 0.37% 50
2024
Q1
$168M Buy
1,275,519
+68,495
+6% +$8.44M 0.39% 52
2023
Q4
$132M Buy
1,207,024
+30,481
+3% +$3.16M 0.35% 60
2023
Q3
$121M Sell
1,176,543
-212,763
-15% -$22.9M 0.37% 56
2023
Q2
$160M Buy
1,389,306
+88,634
+7% +$10.1M 0.5% 36
2023
Q1
$138M Buy
1,300,672
+24,185
+2% +$2.61M 0.48% 41
2022
Q4
$142M Buy
1,276,487
+63,302
+5% +$6.47M 0.54% 27
2022
Q3
$104M Buy
1,213,185
+17,985
+2% +$1.61M 0.44% 47
2022
Q2
$109M Buy
1,195,200
+51,618
+5% +$4.58M 0.48% 37
2022
Q1
$93.8M Buy
1,143,582
+133,471
+13% +$10.5M 0.36% 60
2021
Q4
$77.4M Buy
1,010,111
+137,380
+16% +$10.9M 0.3% 73
2021
Q3
$65.6M Buy
872,731
+124,746
+17% +$9.49M 0.27% 82
2021
Q2
$58.2M Sell
747,985
-1,357
-0.2% -$101K 0.27% 84
2021
Q1
$55.1M Buy
749,342
+492
+0.1% +$36.3K 0.29% 72
2020
Q4
$58.5M Buy
748,850
+73,758
+11% +$5.64M 0.34% 61
2020
Q3
$53.4M Buy
675,092
+63,670
+10% +$4.99M 0.34% 61
2020
Q2
$45.1M Sell
611,422
-261,184
-30% -$19.7M 0.3% 66
2020
Q1
$64.1M Buy
872,606
+47,565
+6% +$3.74M 0.52% 37
2019
Q4
$71.6M Buy
825,041
+22,212
+3% +$1.82M 0.51% 42
2019
Q3
$64.5M Buy
802,829
+13,631
+2% +$1.09M 0.51% 39
2019
Q2
$63.1M Sell
789,198
-95,984
-11% -$7.35M 0.52% 43
2019
Q1
$70.2M Sell
885,182
-66,205
-7% -$4.95M 0.62% 31
2018
Q4
$69.4M Buy
951,387
+4,724
+0.5% +$333K 0.68% 28
2018
Q3
$64.1M Buy
946,663
+47,149
+5% +$3M 0.56% 33
2018
Q2
$52.1M Buy
899,514
+26,049
+3% +$1.47M 0.5% 38
2018
Q1
$45.4M Buy
873,465
+11,208
+1% +$605K 0.45% 41
2017
Q4
$46.3M Sell
862,257
-148,837
-15% -$8.25M 0.47% 42
2017
Q3
$61.8M Buy
1,011,094
+28,625
+3% +$1.74M 0.65% 26
2017
Q2
$60.1M Buy
982,469
+23,747
+2% +$1.45M 0.65% 25
2017
Q1
$58.1M Sell
958,722
-56,237
-6% -$3.41M 0.64% 24
2016
Q4
$57M Buy
1,014,959
+78,039
+8% +$4.57M 0.69% 20
2016
Q3
$55.8M Sell
936,920
-16,887
-2% -$988K 0.72% 18
2016
Q2
$52.4M Buy
953,807
+62,333
+7% +$3.32M 0.72% 23
2016
Q1
$45M Buy
891,474
+83,789
+10% +$4.1M 0.67% 26
2015
Q4
$40.7M Buy
807,685
+127,951
+19% +$6.45M 0.67% 24
2015
Q3
$32M Sell
679,734
-73,612
-10% -$3.91M 0.56% 29
2015
Q2
$40.9M Buy
753,346
+129,169
+21% +$7.24M 0.69% 16
2015
Q1
$34.2M Buy
624,177
+59,511
+11% +$3.37M 0.6% 19
2014
Q4
$30.6M Buy
564,666
+41,976
+8% +$2.34M 0.57% 16
2014
Q3
$29.6M Sell
522,690
-36,949
-7% -$2.07M 0.59% 14
2014
Q2
$30.9M Buy
559,639
+9,780
+2% +$534K 0.44% 21
2014
Q1
$29.8M Buy
549,859
+61,505
+13% +$3.18M 0.46% 21
2013
Q4
$23.3M Buy
488,354
+28,725
+6% +$1.31M 0.38% 31
2013
Q3
$20.9M Buy
459,629
+22,751
+5% +$1.04M 0.38% 33
2013
Q2
$19.4M Buy
+436,878
New +$19.5M 0.39% 32

Other funds holding MRK

Natixis Advisors's MRK Position: Q1 2026 in Review

Natixis Advisors increased its Merck (MRK) stake by 18% in Q1 2026, buying an estimated $51.1M and bringing the position to 2,970,290 shares worth $357M. The position accounts for 0.5% of the portfolio, ranked #26.

Natixis Advisors first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Natixis Advisors held 2,970,290 shares of Merck worth $357M as of Q1 2026.
  • Natixis Advisors bought 442,713 Merck shares in Q1 2026, an estimated $51.1M.
  • Merck made up 0.5% of Natixis Advisors's portfolio in Q1 2026, its #26 holding.
  • Natixis Advisors first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Natixis Advisors's 13F filing for Q1 2026, filed 13 May 2026.